Skip to main content

Research Repository

Advanced Search

2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

Ritschl, Valentin; Stamm, Tanja A; Aletaha, Daniel; Bijlsma, Johannes W J; Böhm, Peter; Dragoi, Razvan Gabriel; Dures, Emma; Estévez-López, Fernando; Gossec, Laure; Iagnocco, Annamaria; Marques, Andrea; Moholt, Ellen; Nudel, Michal; Van Den Bemt, Bart J F; Viktil, Kirsten; Voshaar, Marieke; de Thurah, Annette; Carmona, Loreto

2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice Thumbnail


Authors

Valentin Ritschl

Tanja A Stamm

Daniel Aletaha

Johannes W J Bijlsma

Peter Böhm

Razvan Gabriel Dragoi

Emma Dures Emma2.Dures@uwe.ac.uk
Associate Professor in Rheumatology and Self-management

Fernando Estévez-López

Laure Gossec

Annamaria Iagnocco

Andrea Marques

Ellen Moholt

Michal Nudel

Bart J F Van Den Bemt

Kirsten Viktil

Marieke Voshaar

Annette de Thurah

Loreto Carmona



Abstract

Background Non-adherence to treatment could preclude reaching an optimal outcome. Thirty to 80% of patients with rheumatic and musculoskeletal diseases (RMDs) do not adhere to the agreed treatment. Objectives The objective was to establish points to consider (PtCs) for the prevention, screening, assessment and management of non-adherence to (non-)pharmacological treatments in people with RMDs. Methods An EULAR task force (TF) was established, and the EULAR standardised operating procedures for the development of PtCs were followed. The TF included healthcare providers (HCPs), comprising rheumatologists, nurses, pharmacists, psychologists, physiotherapists, occupational therapists and patient-representatives from 12 European countries. A review of systematic reviews was conducted in advance to support the TF in formulating the PtCs. The level of agreement among the TF was established by anonymous online voting. Results Four overarching principles and nine PtCs were formulated. The PtCs reflect the phases of action on non-adherence. HCPs should assess and discuss adherence with patients on a regular basis and support patients to treatment adherence. As adherence is an agreed behaviour, the treatment has to be tailored to the patients' needs. The level of agreement ranged from 9.5 to 9.9 out of 10. Conclusions These PtCs can help HCPs to support people with RMDs to be more adherent to the agreed treatment plan. The basic scheme being prevent non-adherence by bonding with the patient and building trust, overcoming structural barriers, assessing in a blame-free environment and tailoring the solution to the problem.

Citation

Ritschl, V., Stamm, T. A., Aletaha, D., Bijlsma, J. W. J., Böhm, P., Dragoi, R. G., …Van Den Bemt, B. J. F. (2021). 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Annals of the Rheumatic Diseases, 80(6), 707-713. https://doi.org/10.1136/annrheumdis-2020-218986

Journal Article Type Article
Acceptance Date Oct 26, 2020
Online Publication Date Dec 18, 2020
Publication Date Jun 1, 2021
Deposit Date Jun 10, 2021
Publicly Available Date Jun 10, 2021
Journal Annals of the Rheumatic Diseases
Print ISSN 0003-4967
Electronic ISSN 1468-2060
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 80
Issue 6
Pages 707-713
DOI https://doi.org/10.1136/annrheumdis-2020-218986
Public URL https://uwe-repository.worktribe.com/output/6841045

Files





You might also like



Downloadable Citations